Skip to search.
 BSE Up 0.49% NSE Up 0.79%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.62 Down 0.01(1.51%) 27 Feb 2:29AM
Add to Portfolio
Prev Close:0.63
Open:0.62
Bid:0.40 x 400
Ask:N/A
1y Target Est:1.34
Beta:2.34
Next Earnings Date:N/A
Day's Range:0.61 - 0.64
52wk Range:0.48 - 1.54
Volume:424,857
Avg Vol (3m):708,988
Market Cap:40.47M
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSDown 1.51%40.47M
CELGUp 0.20%98.75B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.49
Quarterly EPS Est (Dec-14) :-0.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback